CN Stock MarketDetailed Quotes
002750 Kunming Longjin Pharmaceutical
- 2.14
- -0.11-4.89%
Market Closed Nov 1 15:00 CST
857.07MMarket Cap-15970P/E (TTM)
2.20High2.14Low169.90KlotVolume2.19Open2.25Pre Close36.61MTurnover4.26%Turnover RatioLossP/E (Static)400.50MShares12.5052wk High1.71P/B853.30MFloat Cap1.4352wk Low2.36Limit Up398.74MShs Float26.32Historical High2.14Limit Down2.67%Amplitude1.43Historical Low--Dividend TTM2.15Avg Price99.80KlotAsk--Div YieldTTM100Lot Size69.70KlotBid
Kunming Longjin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -33.32%54.62M | -28.71%38.83M | -18.26%21.71M | -31.60%103.38M | -31.92%81.91M | -39.02%54.46M | -51.41%26.56M | -75.38%151.14M | -76.93%120.32M | -71.73%89.32M |
| Refunds of taxes and levies | --23.17K | --23.17K | ---- | ---- | ---- | ---- | ---- | --1.4M | --1.4M | --1.4M |
| Cash received relating to other operating activities | -9.31%5.51M | -1.09%3.92M | 78.39%3.56M | -15.61%18.87M | -71.11%6.07M | -38.28%3.97M | -25.08%2M | -32.17%22.36M | 12.67%21.02M | -57.86%6.43M |
| Cash inflows from operating activities | -31.64%60.15M | -26.79%42.77M | -11.50%25.27M | -30.10%122.25M | -38.36%87.98M | -39.85%58.43M | -50.19%28.56M | -72.96%174.9M | -73.58%142.74M | -70.67%97.14M |
| Goods services cash paid | 29.75%11.58M | 3.75%6.59M | -10.87%3.56M | 1.05%17.89M | -37.96%8.93M | -42.32%6.35M | -46.02%4M | -95.48%17.7M | -96.00%14.39M | -95.10%11.01M |
| Staff behalf paid | 1.65%24.77M | 12.14%18.44M | 10.55%10.3M | 12.28%31.59M | 12.34%24.36M | 14.17%16.45M | 31.71%9.32M | -33.85%28.14M | -37.63%21.69M | -37.78%14.41M |
| All taxes paid | -65.24%6.53M | -72.23%4.15M | -75.22%2.36M | 57.55%20.67M | 54.83%18.78M | 111.67%14.96M | 161.92%9.52M | -56.45%13.12M | -49.13%12.13M | -55.43%7.07M |
| Cash paid relating to other operating activities | -40.33%50M | -27.83%44.66M | -68.69%13.81M | -29.93%91.36M | -23.71%83.81M | -25.28%61.87M | -10.69%44.11M | -33.86%130.38M | -21.40%109.85M | -10.89%82.8M |
| Cash outflows from operating activities | -31.64%92.88M | -25.88%73.85M | -55.14%30.04M | -14.70%161.51M | -14.03%135.88M | -13.58%99.63M | -0.83%66.95M | -71.38%189.34M | -71.69%158.05M | -67.68%115.29M |
| Net cash flows from operating activities | 31.65%-32.73M | 24.59%-31.07M | 87.59%-4.76M | -171.83%-39.26M | -212.80%-47.89M | -127.09%-41.2M | -276.88%-38.4M | 2.44%-14.44M | 14.87%-15.31M | 28.78%-18.14M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -31.18%690.46M | -4.95%668.24M | 48.51%334.15M | 18.03%1.34B | 27.31%1B | 33.64%703M | 4.41%225M | 0.86%1.14B | -2.98%788.06M | 3.49%526.03M |
| Cash received from returns on investments | -48.75%2.26M | -25.80%2.12M | -40.58%905.57K | -33.85%6.2M | -35.52%4.41M | -36.07%2.86M | -10.00%1.52M | 2.54%9.37M | 4.13%6.84M | 13.58%4.47M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --243K | --38K | ---- | ---- | ---- | ---- | ---- | -17.18%343.2K | 200.69%350K | 268.42%350K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 51.06%17.71M | --14.29M | ---- |
| Cash received relating to other investing activities | --4M | --4M | ---- | --1.3M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -30.83%696.97M | -4.46%674.39M | 47.91%335.06M | 15.90%1.35B | 24.47%1.01B | 32.97%705.86M | 4.30%226.52M | 1.38%1.17B | -1.15%809.55M | 3.61%530.85M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -63.51%4.41M | -57.18%4.24M | -45.36%2.35M | -37.89%15.67M | -38.94%12.1M | 42.92%9.89M | 175.90%4.29M | 143.65%25.22M | 95.61%19.81M | -8.07%6.92M |
| Cash paid to acquire investments | -41.89%606.38M | -21.16%585.01M | 86.23%419.01M | 22.34%1.25B | 31.06%1.04B | 51.06%742M | 2.18%225M | -12.36%1.03B | -5.53%796.2M | -6.58%491.2M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | --5.05M | --5.05M | --6.35M | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --25.99M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -42.41%610.8M | -22.15%589.25M | 78.81%421.36M | 23.36%1.3B | 29.98%1.06B | 51.96%756.95M | 6.26%235.65M | -10.99%1.05B | -4.33%816.01M | -6.60%498.12M |
| Net cash flows from investing activities | 262.61%86.17M | 266.67%85.15M | -846.04%-86.3M | -51.69%56.04M | -720.49%-52.99M | -256.10%-51.09M | -99.94%-9.12M | 492.30%116M | 80.97%-6.46M | 255.86%32.73M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -99.42%18.02K | ---- | ---- | --14.6M | --3.09M | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --14.6M | --3.09M | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | --9.98M | --9.98M | --9.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | --2.4M | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 301.52%12.4M | --11.98M | --9.98M | --14.6M | --3.09M | ---- | ---- | ---- | ---- | ---- |
| Borrowing repayment | --8.98M | --4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | 236.15%159.74K | 136.25%112.26K | ---- | --47.52K | --47.52K | --47.52K | ---- | ---- | ---- | ---- |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --47.52K | --47.52K | --47.52K | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | --2.5M | ---- | ---- | -6.81%11.67M | ---- | ---- | ---- | 544.98%12.52M | ---- | ---- |
| Cash outflows from financing activities | 24,394.40%11.64M | 8,553.75%4.11M | ---- | -6.43%11.72M | --47.52K | --47.52K | ---- | 436.26%12.52M | ---- | ---- |
| Net cash flows from financing activities | -75.06%758.28K | 16,656.68%7.87M | --9.98M | 123.04%2.89M | --3.04M | ---47.52K | ---- | -155.82%-12.52M | ---- | ---- |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 155.39%54.19M | 167.08%61.94M | -70.64%-81.08M | -77.91%19.66M | -349.45%-97.84M | -733.21%-92.34M | -222.15%-47.52M | 505.83%89.03M | 28.68%-21.77M | 158.98%14.58M |
| Add:Begin period cash and cash equivalents | 10.29%210.74M | 10.29%210.74M | 10.29%210.74M | 87.25%191.07M | 87.25%191.07M | 87.25%191.07M | 87.25%191.07M | -17.70%102.04M | -17.70%102.04M | -17.70%102.04M |
| End period cash equivalent | 184.16%264.93M | 176.18%272.68M | -9.68%129.65M | 10.29%210.74M | 16.15%93.23M | -15.34%98.73M | 64.46%143.55M | 87.25%191.07M | -14.11%80.27M | 17.50%116.62M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data